XSNX (Novaccess Global) E10: $0.00 (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSNX Novaccess Global Inc XSNX
12 GF Score
Price $0.00
View Full Analysis

What is Novaccess Global E10?

Novaccess Global XSNX 12 E10 is $0.00 as of Sep. 2024. GuruFocus rates XSNX with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novaccess Global's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.041. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-02), Novaccess Global's current stock price is $0.0001. Novaccess Global's E10 for the quarter that ended in Sep. 2024 was $0.00. Novaccess Global's Shiller PE Ratio of today is .


Novaccess Global  (OTCPK:XSNX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novaccess Global E10 Related Terms


Novaccess Global E10 Historical Data

* Premium members only.

The historical data trend for Novaccess Global's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novaccess Global E10 Chart

Novaccess Global Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.56 -0.89 0.00 -0.86 0.00

Novaccess Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 -0.84 -0.76 -0.73 0.00

XSNX vs NBIO, BTAX, PXMD: E10 Comparison

For the Biotechnology subindustry, Novaccess Global's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novaccess Global Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novaccess Global's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novaccess Global's Shiller PE Ratio falls into.


XSNX
12GF Score
Novaccess Global Inc XSNX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novaccess Global E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novaccess Global's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.041/315.3010*315.3010
=-0.041

Current CPI (Sep. 2024) = 315.3010.

Novaccess Global Quarterly Data

per share eps CPI Adj_EPS
201412 0.031 234.812 0.042
201503 -1.352 236.119 -1.805
201506 -0.095 238.638 -0.126
201509 -0.515 237.945 -0.682
201512 -0.045 236.525 -0.060
201603 0.198 238.132 0.262
201606 -0.323 241.018 -0.423
201609 -0.178 241.428 -0.232
201612 -0.042 241.432 -0.055
201703 0.026 243.801 0.034
201706 -0.165 244.955 -0.212
201709 -0.356 246.819 -0.455
201712 -0.057 246.524 -0.073
201803 -0.331 249.554 -0.418
201806 -4.458 251.989 -5.578
201809 7.100 252.439 8.868
201812 0.254 251.233 0.319
201903 0.086 254.202 0.107
201906 -0.287 256.143 -0.353
201909 0.572 256.759 0.702
201912 -0.060 256.974 -0.074
202003 0.006 258.115 0.007
202006 0.120 257.797 0.147
202009 -4.624 260.280 -5.601
202012 0.020 260.474 0.024
202103 -0.050 264.877 -0.060
202106 -0.160 271.696 -0.186
202109 0.030 274.310 0.034
202112 -0.010 278.802 -0.011
202203 -0.080 287.504 -0.088
202206 -0.030 296.311 -0.032
202209 0.000 296.808 0.000
202212 -0.140 296.797 -0.149
202303 -0.030 301.836 -0.031
202306 -0.040 305.109 -0.041
202309 -0.080 307.789 -0.082
202312 0.010 306.746 0.010
202403 -0.020 312.332 -0.020
202406 -0.020 314.175 -0.020
202409 -0.041 315.301 -0.041

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.00 mean?
Novaccess Global (XSNX) has a E10 of $0.00 as of Sep. 2024. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novaccess Global and its competitors.
Is Novaccess Global's E10 too high?
Novaccess Global's current E10 is $0.00. Overall, Novaccess Global has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novaccess Global's E10 compare to NBIO and BTAX?
Novaccess Global's E10 of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Novaccess Global and its competitors. Novaccess Global's current E10 is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novaccess Global stock overvalued right now?
Novaccess Global (XSNX) has a current E10 of $0.00. The current E10 is $0.00. Novaccess Global's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Novaccess Global (XSNX), the current E10 is $0.00 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novaccess Global Business Description

Address 459 Columbus Avenue, No. 607, New York, NY, USA, 10024
Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.
12GF Score

Get the complete analysis for XSNX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price